We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Show more
EB-003 is a novel, neuroplastogenic molecule designed to treat severe mental health disorders without the hallucinogenic effect typically associated with psychedelic-based compounds Enveric is...
Enveric Biosciences (NASDAQ: ENVB) (βEnvericβ or the βCompanyβ), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of...
Revealed seven classes of promising novel drug candidates discovered using Envericβs Psybraryβ’ and PsyAIβ’ drug discovery and artificial intelligence (AI) platforms Launched business development...
MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences...
Biotechnology licensee expected to progress methods targeting breast and other cancers using cannabinoids in combination with chemotherapeutic drugs Enveric Biosciences, Inc (NASDAQ: ENVB), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1067 | -17.0392845736 | 0.6262 | 0.6395 | 0.49 | 159995 | 0.53565587 | CS |
4 | -0.2406 | -31.6537297724 | 0.7601 | 0.788 | 0.49 | 106937 | 0.62579722 | CS |
12 | -0.5005 | -49.068627451 | 1.02 | 1.03 | 0.49 | 503544 | 0.92766706 | CS |
26 | -0.7505 | -59.094488189 | 1.27 | 2.92 | 0.49 | 2445964 | 1.3233092 | CS |
52 | -2.5605 | -83.1331168831 | 3.08 | 3.8978 | 0.49 | 1249996 | 1.35005592 | CS |
156 | -1.5505 | -74.9033816425 | 2.07 | 14.87 | 0.1551 | 1611165 | 1.95192813 | CS |
260 | -5.2805 | -91.0431034483 | 5.8 | 14.87 | 0.1551 | 1986286 | 2.5808377 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions